Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathology
Alba Navarro-Romero, Irene Fernández-González, Jordi Riera, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

More than meets the eye in Parkinson’s disease and other synucleinopathies: from proteinopathy to lipidopathy
Manuel Flores‐León, Tiago F. Outeiro
Acta Neuropathologica (2023) Vol. 146, Iss. 3, pp. 369-385
Open Access | Times Cited: 24
Targeting the GBA1 pathway to slow Parkinson disease: Insights into clinical aspects, pathogenic mechanisms and new therapeutic avenues
Elisa Menozzi, Marco Toffoli, Anthony H.V. Schapira
Pharmacology & Therapeutics (2023) Vol. 246, pp. 108419-108419
Open Access | Times Cited: 23
Lysosomal storage, impaired autophagy and innate immunity in Gaucher and Parkinson's diseases: insights for drug discovery
Alexander Hull, Magda L. Atilano, Laith Gergi, et al.
Philosophical Transactions of the Royal Society B Biological Sciences (2024) Vol. 379, Iss. 1899
Open Access | Times Cited: 12
Autophagy, aging, and age-related neurodegeneration
J. E. Palmer, Niall Wilson, Sung Min Son, et al.
Neuron (2024)
Open Access | Times Cited: 12
The Role of Chaperone-Mediated Autophagy in Tissue Homeostasis and Disease Pathogenesis
Rut Valdor, Marta Martínez‐Vicente
Biomedicines (2024) Vol. 12, Iss. 2, pp. 257-257
Open Access | Times Cited: 11
Modeling Parkinson’s disease pathology in human dopaminergic neurons by sequential exposure to α-synuclein fibrils and proinflammatory cytokines
Armin Bayati, Riham Ayoubi, Adriana Aguila, et al.
Nature Neuroscience (2024)
Closed Access | Times Cited: 8
Evolving Landscape of Parkinson’s Disease Research: Challenges and Perspectives
Rumiana Koynova, Janet M. Sasso, Qiongqiong Angela Zhou
ACS Omega (2025) Vol. 10, Iss. 2, pp. 1864-1892
Open Access | Times Cited: 1
Pathogenesis of Parkinson’s Disease
Bin Xiao, Zhidong Zhou, Yinxia Chao, et al.
Neurologic Clinics (2025)
Closed Access | Times Cited: 1
The Consequences of GBA Deficiency in the Autophagy–Lysosome System in Parkinson’s Disease Associated with GBA
Eddie Pradas, Marta Martínez‐Vicente
Cells (2023) Vol. 12, Iss. 1, pp. 191-191
Open Access | Times Cited: 20
The regulatory role of lipophagy in central nervous system diseases
Zhuoqing Lan, Zi-yi Ge, Shu-kai Lv, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 20
Lysophagy protects against propagation of α-synuclein aggregation through ruptured lysosomal vesicles
Keita Kakuda, Kensuke Ikenaka, Akiko Kuma, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 121, Iss. 1
Open Access | Times Cited: 18
GBA1 inactivation in oligodendrocytes affects myelination and induces neurodegenerative hallmarks and lipid dyshomeostasis in mice
Di Gregorio, Loris Russo, Enrica Torretta, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 6
The Endo-lysosomal System in Parkinson’s Disease: Expanding the Horizon
Amitha Muraleedharan, Benoît Vanderperre
Journal of Molecular Biology (2023) Vol. 435, Iss. 12, pp. 168140-168140
Open Access | Times Cited: 14
The lysosomal β-glucocerebrosidase strikes mitochondria: implications for Parkinson’s therapeutics
Juan Carlos Rubilar, Tiago F. Outeiro, Andrés D. Klein
Brain (2024) Vol. 147, Iss. 8, pp. 2610-2620
Closed Access | Times Cited: 4
Insulin resistance compromises midbrain organoid neuronal activity and metabolic efficiency predisposing to Parkinson’s disease pathology
Alise Žagare, Janis Kurlovics, Catarina Serra-Almeida, et al.
Journal of Tissue Engineering (2025) Vol. 16
Open Access
Targeting mitochondria-regulated ferroptosis: A new frontier in Parkinson’s Disease therapy
Wenjun Wang, Elizabeth Rosalind Thomas, Rui Xiao, et al.
Neuropharmacology (2025), pp. 110439-110439
Open Access
Elevated parkinsonism pathological markers in dopaminergic neurons with developmental exposure to atrazine
Han Zhao, Junkai Xie, Shichen Wu, et al.
The Science of The Total Environment (2023) Vol. 908, pp. 168307-168307
Open Access | Times Cited: 12
Autophagy‑regulating miRNAs: Novel therapeutic targets for Parkinson's disease (Review)
Zhenwang Ma, Hao Liang, Bingcheng Hu, et al.
International Journal of Molecular Medicine (2023) Vol. 51, Iss. 6
Open Access | Times Cited: 11
Deregulation of mTORC1-TFEB axis in human iPSC model of GBA1-associated Parkinson’s disease
Fahad Mubariz, Afsoon Saadin, Nicholas Lingenfelter, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 11
The Dual Role of Chaperone-mediated Autophagy in the Response and Resistance to Cancer Immunotherapy
Mohammadreza Saberiyan, Sarah Gholami, Mahsa Ejlalidiz, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 210, pp. 104700-104700
Open Access
PINK1 is a target of T cell responses in Parkinson’s disease
Gregory P. Williams, T. Michaelis, João Rodrigues Lima-Júnior, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Should evidence of an autolysosomal de-acidification defect in Alzheimer and Parkinson diseases call for caution in prescribing chronic PPI and DMARD?
Sandy Giuliano, Christopher Montemagno, Marie Angela Domdom, et al.
Autophagy (2023) Vol. 19, Iss. 10, pp. 2800-2806
Open Access | Times Cited: 7
Identification and characterization of nanobodies acting as molecular chaperones for glucocerebrosidase through a novel allosteric mechanism
Thomas Dal Maso, Chiara Sinisgalli, Gianluca Zilio, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Evaluation of a Liquid Chromatography–Tandem Mass Spectrometry Method for the Analysis of Glucosylceramide and Galactosylceramide Isoforms in Cerebrospinal Fluid of Parkinson’s Disease Patients
Laura Castillo‐Ribelles, Jose Antonio Arranz-Amo, Jorge Hernández‐Vara, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 31, pp. 12875-12882
Closed Access | Times Cited: 2
Live cell in situ lysosomal GCase activity correlates to alpha-synuclein levels in human differentiated neurons with LRRK2 and GBA1 mutations
Adahir Labrador‐Garrido, Siying Zhong, Laura P. Hughes, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top